The traditional view of psychiatric disorders claims that positive symptoms are associated with hyperdopaminergic activity and mediated by D2R, while deficits in D1R-mediated dopamine activity are responsible for negative symptoms and cognitive impairment (Lindenmayer et al., 2013; Locke et al., 2018). The gene discussed is DRD2; the disease is Cognitive impairment.